Cancer News: A Novel Cellular Mechanism Used to Repair DNA Damage is Revealed & more...

Fri, 26 Apr 2024 20:50:30 -0700

Please click here to view this in your browser.

A Novel Cellular Mechanism Used to Repair DNA Damage is Revealed

The human genome is contained within the nucleus of cells. The genome is well protected, but many things can cause DNA damage, including aging, some drugs, and environmental factors like UV rays or pollution. DNA damage can be a major problem, and the cell has mechanisms to detect and repair that damage. When both ...

Aspirin Reduces Cancer Progression

Aspirin is an over-the-counter medication used to reduce swelling and relieve pain. It is a salicylate medication, which means it reduces the formation of prostaglandins, which are critical in the process of inflammation, and prevents the formation of platelets. In general, it is given to reduce fever and help ...

Game-Changing New Receptor Unlocks the Potential of CAR-T Cell Therapy

Exciting cancer therapy innovations were announced in Cell Reports Medicine in the realm CAR-T-cell therapy (chimeric antigen receptor T cell). By designing a new cytokine receptor, Yoshikawa et al. of Keio University in Tokyo have elevate the efficacy and ...

Cryoablation Presents a New Avenue for Breast Cancer Treatment

Cryoablation (also called cryosurgery or cryotherapy) uses very low temperatures to freeze abnormal tissue, destroying it during freezing. A medical professional uses a cryoprobe, which is cooled with liquid nitrogen or compressed argon and pressed against the treatment area. Cryoablation does not require a ...

Interactions between Immune Cells and Cancer Cells Regulate Cancer Cachexia

Cachexia, defined as a loss of body weight, fat, and muscle mass that occurs in patients with chronic diseases, including cancer, remains a notable clinical challenge. With limited viable treatment strategies, cachexia can diminish the quality of life of ...

Using AI to predict cancer treatment response

A team of researchers at Cancer Molecular Therapeutics Program at Sanford Burnham Prebys have designed a new AI system that could help cancer specialists determine which patients are most likely to respond to and benefit from certain targeted cancer treatments. The team’s research is published in a recent ...

UPCOMING WEBINARS

Advancing cancer organoid drug screening with novel media systems

Dr. Christophe Deben, Ph.D. Oncology and Cancer Biology - Professor Tumor Biology and Organoids, University of Antwerp

Dr. Colin Paul - Cell Biology R&D Staff Scientist, Thermo Fisher Scientific.

Explore the latest developments in cancer organoid (tumoroid) technology and the promising implications for drug screening during this two-part webinar. In the first half, Colin Paul will discuss the capabilities of OncoPro medium, a novel system that simplifies the use of tumoroids for drug screening applications. This session will review potential areas of optimization and highlight how OncoPro ...

MAY 08, 2024 7:00 AM PDT

Expand your Multiomic Capabilities with RNAscope™

Blake McAlpin, PhD - Field Application Scientist, Advanced Cell Diagnostics, a Bio-Techne company

Paul Liu, Ph.D. - Sr. Product Manager, Advanced Cell Diagnostics, a Bio-Techne company

In this webinar we will provide an overview of RNAscope™ ISH technology, then discuss our new RNAscope multiomic applications coming soon. RNAscope is the gold standard for RNA ISH -providing single-molecule sensitivity and unmatched specificity at subcellular resolution. Backed by over 10,000 peer reviewed publications, RNAscope has enabled researchers to reveal ground-breaking biologic ...

MAY 08, 2024 8:00 AM PDT

See More Webinars

SCIENTIFIC PRODUCTS

INFORS HT

Techfors Pilot Bioreactor

MAXCYTE

ExPERT STx™ Scalable static or flow electroporation

SARTORIUS

Microsart® e.motion Membrane Filters

CREATIVE BIOLABS

Human Anti-gp120 (HIV-1/Clade B) Recombinant...

BECKMAN COULTER LIFE SCIENCES